ST
SURGE Therapeutics
Biotechnology · Cambridge, Massachusetts, United StatesAbout
They aim to create a world where all cancer patients undergoing surgical tumor resection can receive intraoperative immunotherapy to prevent post-surgical recurrence and metastasis.
Company details may include data from People Data Labs, licensed CC BY 4.0.